PlainRecalls
FDA Drug Moderate Class II Terminated

Dutasteride and Tamsulosin HCl Capsules, 0.5 mg/ 0.4 mg, packaged in a) 30-count bottle (NDC 0591-3771-30), b) 90-count bottle (NDC 0591-3771-19), Rx only, Manufactured by: Actavis Laboratories FL, Inc. Fort Lauderdale, FL 33314 USA; Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054 USA.

Reported: November 8, 2017 Initiated: October 25, 2017 #D-0069-2018

Product Description

Dutasteride and Tamsulosin HCl Capsules, 0.5 mg/ 0.4 mg, packaged in a) 30-count bottle (NDC 0591-3771-30), b) 90-count bottle (NDC 0591-3771-19), Rx only, Manufactured by: Actavis Laboratories FL, Inc. Fort Lauderdale, FL 33314 USA; Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054 USA.

Reason for Recall

Failed dissolution specifications; all lots within expiry are being recalled due to out of specification dissolution results.

Details

Recalling Firm
Teva Pharmaceuticals USA
Units Affected
140,993 bottles
Distribution
Nationwide in the USA and Puerto Rico.
Location
North Wales, PA

Frequently Asked Questions

What product was recalled?
Dutasteride and Tamsulosin HCl Capsules, 0.5 mg/ 0.4 mg, packaged in a) 30-count bottle (NDC 0591-3771-30), b) 90-count bottle (NDC 0591-3771-19), Rx only, Manufactured by: Actavis Laboratories FL, Inc. Fort Lauderdale, FL 33314 USA; Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054 USA.. Recalled by Teva Pharmaceuticals USA. Units affected: 140,993 bottles.
Why was this product recalled?
Failed dissolution specifications; all lots within expiry are being recalled due to out of specification dissolution results.
Which agency issued this recall?
This recall was issued by the FDA Drug on November 8, 2017. Severity: Moderate. Recall number: D-0069-2018.